Literature DB >> 1515979

Familial nasopharyngeal carcinoma in patients who are not Chinese.

P H Levine1, A G Pocinki, P Madigan, S Bale.   

Abstract

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignancy that is prominent in Cantonese Chinese people. It is presumed to result from an interaction of genetic and environmental factors, including the Epstein-Barr virus (EBV). In an attempt to further clarify the pathogenesis of this disease, an evaluation of NPC occurring in racial/ethnic groups not considered susceptible to this disease could be informative.
METHODS: A white family with NPC occurring in three siblings was investigated and information was gleaned from literature on other reports of familial NPC in non-Chinese families.
RESULTS: In the family being investigated, another genetically determined disease, hemophilia, was identified. Radiation early in life was noted to be a possible risk factor for NPC in the proband. A review of familial NPC in the white population revealed that in contrast to sporadic NPC, which is usually of the well-differentiated type, familial NPC usually is poorly differentiated.
CONCLUSIONS: Familial NPC offers an important opportunity to investigate the etiology of this disease. With newer laboratory techniques to investigate pathogenetic mechanisms, detailed evaluations of non-Chinese NPC families may become increasingly important.

Entities:  

Mesh:

Year:  1992        PMID: 1515979     DOI: 10.1002/1097-0142(19920901)70:5<1024::aid-cncr2820700503>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Nasopharyngeal carcinoma.

Authors:  Muhyi Al-Sarraf; Maryada S Reddy
Journal:  Curr Treat Options Oncol       Date:  2002-02

2.  Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.

Authors:  Nehla Mokni Baizig; Patrice Morand; Jean Marie Seigneurin; Hamouda Boussen; Asma Fourati; Said Gritli; Zeineb Oueslati; Slim Touati; Amor Gamoudi; Mansour Ben Abdallah; Michèle El May; Ahmed El May
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-30       Impact factor: 2.503

3.  Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk.

Authors:  Wan-Lun Hsu; Kelly J Yu; Yin-Chu Chien; Chun-Ju Chiang; Yu-Juen Cheng; Jen-Yang Chen; Mei-Ying Liu; Sheng-Ping Chou; San-Lin You; Mow-Ming Hsu; Pei-Jen Lou; Cheng-Ping Wang; Ji-Hong Hong; Yi-Shing Leu; Ming-Hsui Tsai; Mao-Chang Su; Sen-Tien Tsai; Wen-Yuan Chao; Luo-Ping Ger; Peir-Rong Chen; Czau-Siung Yang; Allan Hildesheim; Scott R Diehl; Chien-Jen Chen
Journal:  Am J Epidemiol       Date:  2010-12-10       Impact factor: 4.897

4.  Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening.

Authors:  Wai Tong Ng; Cheuk Wai Choi; Michael C H Lee; Siu Hong Chan; Tsz Kok Yau; Anne W M Lee
Journal:  Fam Cancer       Date:  2008-08-26       Impact factor: 2.375

5.  Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma.

Authors:  Xuemei Ji; Conghua Xie; Desheng Hu; Xia Fan; Yajuan Zhou; Yingjie Zheng
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

6.  The progress on genetic analysis of nasopharyngeal carcinoma.

Authors:  Xiaofeng Zhou; Jing Cui; Virgilia Macias; André A Kajdacsy-Balla; Hui Ye; Jianguang Wang; P Nagesh Rao
Journal:  Comp Funct Genomics       Date:  2007

Review 7.  Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma.

Authors:  Susanna Hilda Hutajulu; Johan Kurnianda; I Bing Tan; Jaap M Middeldorp
Journal:  Ther Clin Risk Manag       Date:  2014-09-05       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.